Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancer Gene Therapy|August 10, 2024
PHF10 inhibits gastric epithelium differentiation and induces gastric cancer carcinogenesisZhiyuan Fan, Wenjing Yan, Jianfang Li, et al.
Cancer Biomarkers : Section a of Disease Markers|April 26, 2021
Identification of novel autoantibodies in ascites of relapsed paclitaxel-resistant gastric cancer with peritoneal metastasis using immunome protein microarrays and proteomicsZhongyin Yang, Chao Yan, Wentao Liu, et al.
Cancer Cell International|April 13, 2025
Identification and validation of platinum resistance signature in gastric cancerWenjing Yan, Nan Zhu, Yupeng Zhao, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 8, 2018
KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancerZhongyin Yang, Chen Li, Chao Yan, et al.
BMC Cancer|March 29, 2011
P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cellsMin Wei, Zhiwei Wang, Hongliang Yao, et al.
Journal of Cancer|January 4, 2021
Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer CellsZhongyin Yang, Chao Yan, Zhenjia Yu, et al.
EJNMMI Research|April 21, 2025
Preoperative assessment and prognostic prediction of gastric cancer patients with peritoneal metastasis using <sup>18</sup>F-FDG PET/CT before conversion surgeryYao Peng, Min Shi, Daxi Xiong, et al.
BMC Cancer|January 10, 2014
Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesteroneMin Wei, Qi He, Zhongyin Yang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 23, 2020
Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasisZhongyin Yang, Chen Li, Wentao Liu, et al.
Cancer Science|April 28, 2011
Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer modelMin Wei, Li Zhu, Yafen Li, et al.
Pageof 3